Integra LifeSciences (IART): Volume dana dhuwit perusahaan

Simbol resmi perusahaan Integra (IART)

Integra LifeSciences is reforming its manufacturing standards following FDA inspections, which is clearly demonstrated by its current cash position. The value of 0.31 captures the liquidity metric level during this period. Integra LifeSciences is implementing advanced bioengineering solutions for tissue regeneration, leveraging stable hospital demand and the regular updating of its neurosurgery implant portfolio.

Dana dhuwit perusahaan: Integra LifeSciences Inc. (IART) kanggo 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Integra LifeSciences Corp (IART)

Analisis wiwitan perusahaan:Integra LifeSciences Inc. IART
Produk merek Integra LifeSciences Holdings Corporation

The margin of safety for Integra LifeSciences (IART) is determined by the volume of liquid assets, which ensure operational resilience and the ability to generate interest income. By analyzing cash dynamics, an investor assesses the company's capacity to fund production restarts and M&A deals within the neurosurgery sector, transforming this asset into a tool for strategic business scaling.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Establishment Labs Inc - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Beta Bionics Inc BBNX|IRADIMED Corp - Volume dana dhuwit perusahaan|Aset likuid perusahaan Embecta Corp EMBC|Tandem Diabetes Care, Inc. (TNDM) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan AXGN (Axogen Surgical)|Dana dhuwit perusahaan si-bone.com|Dhuwit awis perusahaan Orthofix Medical Inc. (OFIX)|Dana dhuwit perusahaan Bioventus Corp (BVS)|KIDS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Treace Medical Concepts TMCI|SRTA: Dhuwit awis lan setara dhuwit awis perusahaan|CARL: Dhuwit awis perusahaan|rxsight.com - Gunggung dana dhuwit perusahaan|CLPT: Volume dana dhuwit perusahaan|STXS - Aset likuid perusahaan|STIM (neurostar.com) - Volume dana dhuwit perusahaan|Sight Sciences, Inc (SGHT) - Aset likuid perusahaan|Volume dana dhuwit perusahaan OBIO|Aset likuid perusahaan Anika Therapeutics Inc.|Dana dhuwit perusahaan InspireMD, Inc. NSPR|Sisa dhuwit perusahaan ZJYL|VANI - Dana dhuwit perusahaan|Xtant Medical Holdings, Inc. - Gunggung dana dhuwit perusahaan|NeuroOne (NMTC) - Dana dhuwit perusahaan|Modular Med (MODD) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Myomo, Inc|Dhuwit awis perusahaan Envoy Medical (COCH)|Volume dana dhuwit perusahaan VVOS|NVNO (enVVeno Corp) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SINT (Sintx Technologies)|TNON: Dhuwit awis lan setara dhuwit awis perusahaan|Lifeward - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AMIX (Autonomix Medical)|IVF: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bone Biologics Corporation BBLG|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)